Clifford Swan Investment Counsel LLC Cuts Stock Position in The Procter & Gamble Company (NYSE:PG)

Clifford Swan Investment Counsel LLC trimmed its stake in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 0.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 166,118 shares of the company’s stock after selling 651 shares during the period. Procter & Gamble accounts for 0.9% of Clifford Swan Investment Counsel LLC’s holdings, making the stock its 27th biggest position. Clifford Swan Investment Counsel LLC’s holdings in Procter & Gamble were worth $24,343,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of the stock. AllGen Financial Advisors Inc. raised its stake in Procter & Gamble by 0.3% in the 4th quarter. AllGen Financial Advisors Inc. now owns 20,679 shares of the company’s stock valued at $3,030,000 after purchasing an additional 68 shares during the last quarter. Metis Global Partners LLC raised its position in shares of Procter & Gamble by 15.7% in the fourth quarter. Metis Global Partners LLC now owns 115,039 shares of the company’s stock valued at $16,858,000 after buying an additional 15,599 shares during the last quarter. TCI Wealth Advisors Inc. lifted its stake in shares of Procter & Gamble by 16.6% in the fourth quarter. TCI Wealth Advisors Inc. now owns 15,164 shares of the company’s stock worth $2,222,000 after buying an additional 2,157 shares in the last quarter. W.H. Cornerstone Investments Inc. boosted its position in Procter & Gamble by 14.4% during the fourth quarter. W.H. Cornerstone Investments Inc. now owns 8,511 shares of the company’s stock worth $1,247,000 after acquiring an additional 1,074 shares during the last quarter. Finally, Connecticut Wealth Management LLC grew its stake in Procter & Gamble by 1.3% during the 4th quarter. Connecticut Wealth Management LLC now owns 16,599 shares of the company’s stock valued at $2,432,000 after acquiring an additional 210 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Buying and Selling

In other news, insider Susan Street Whaley sold 3,865 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $160.60, for a total value of $620,719.00. Following the sale, the insider now directly owns 11,886 shares in the company, valued at $1,908,891.60. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, insider Susan Street Whaley sold 3,865 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $160.60, for a total transaction of $620,719.00. Following the sale, the insider now directly owns 11,886 shares in the company, valued at $1,908,891.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO R. Alexandra Keith sold 776 shares of Procter & Gamble stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $158.11, for a total transaction of $122,693.36. Following the completion of the transaction, the chief executive officer now owns 4,859 shares of the company’s stock, valued at approximately $768,256.49. The disclosure for this sale can be found here. Insiders have sold a total of 86,865 shares of company stock valued at $14,059,180 in the last ninety days. Company insiders own 0.17% of the company’s stock.

Procter & Gamble Trading Up 0.4 %

NYSE:PG traded up $0.62 during trading hours on Friday, reaching $164.46. 5,581,692 shares of the stock were exchanged, compared to its average volume of 6,941,715. The Procter & Gamble Company has a twelve month low of $141.45 and a twelve month high of $164.71. The company has a quick ratio of 0.48, a current ratio of 0.69 and a debt-to-equity ratio of 0.49. The business has a 50-day moving average of $160.01 and a two-hundred day moving average of $154.25. The company has a market capitalization of $388.15 billion, a price-to-earnings ratio of 26.87, a PEG ratio of 3.34 and a beta of 0.43.

Procter & Gamble (NYSE:PGGet Free Report) last posted its earnings results on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.10. The firm had revenue of $20.20 billion for the quarter, compared to analyst estimates of $20.43 billion. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. Procter & Gamble’s revenue was up .6% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.37 EPS. On average, equities analysts predict that The Procter & Gamble Company will post 6.55 EPS for the current year.

Procter & Gamble Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be issued a $1.0065 dividend. The ex-dividend date is Thursday, April 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.45%. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s payout ratio is 65.85%.

Wall Street Analysts Forecast Growth

PG has been the topic of several recent research reports. UBS Group boosted their target price on Procter & Gamble from $172.00 to $178.00 and gave the stock a “buy” rating in a report on Wednesday, January 24th. Stifel Nicolaus upped their target price on Procter & Gamble from $155.00 to $157.00 and gave the company a “hold” rating in a report on Wednesday, January 24th. Deutsche Bank Aktiengesellschaft reduced their price target on Procter & Gamble from $172.00 to $171.00 and set a “buy” rating on the stock in a report on Monday, April 22nd. Truist Financial raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and upped their price objective for the company from $160.00 to $175.00 in a report on Monday, March 11th. Finally, Jefferies Financial Group lifted their target price on shares of Procter & Gamble from $175.00 to $182.00 and gave the stock a “buy” rating in a research note on Monday, April 22nd. Seven equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $169.76.

Get Our Latest Analysis on Procter & Gamble

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Read More

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.